Floatz logo

Cyclophosphamide

Recurrent Adult Immunoblastic Large Cell Lymphoma

Essen BiotechSmall moleculePhase 3Active
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Recurrent Adult Immunoblastic Large Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Fludarabine
Essen Biotech
Phase 2BBB
ETOPOSIDE
Fred Hutchinson Cancer Center
Phase 3BBB
CYCLOSPORIN A
National Cancer Institute (NCI)
Phase 2BBB
Monomethyl Fumarate
University of Medicine and Dentistry of New Jersey
Phase 2BBB
DEXAMETHASONE
Mayo Clinic
Phase 2BBB

View all 50 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →